Lund SLE Research Group
1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus
- A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus
- Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity
- Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine.
- Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus
- Novel risk genes for systemic lupus erythematosus predicted by random forest classification
- 2001
- Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden